Serotonin Reuptake Inhibitor
Showing 1 - 25 of 8,603
Major Depressive Disorder With Anhedonia and Inadequate Response
Not yet recruiting
- Depressive Disorder, Major
- No Intervention
- (no location specified)
Apr 24, 2023
Haemorrhage Between Vortioxetine Tablet Treatment and Selective
Not yet recruiting
- Major Depressive Disorder
- Vortioxetine Tablet
- SSRI
- (no location specified)
Jun 28, 2023
Selective Serotonin Reuptake Inhibitor on Cognition, Sexual
Recruiting
- Menopause
- Hormone replacement therapy
- Selective serotonin reuptake inhibitors
-
São Bernardo do Campo, SP, BrazilCentro de Atenção Integral à Saúde da Mulher
Jan 20, 2022
Major Depressive Disorder Who Have HadInadequate Response
Terminated
- Depressive Disorder, Major
- Standard of Care (SOC)
-
San Francisco, California
- +3 more
Dec 6, 2022
Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,
Recruiting
- Geriatric Depression
- Cognitive Impairment
- Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram)
-
Beijing, ChinaBeijing Anding Hospital Affiliated to Capital Medical University
Oct 18, 2022
Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)
Recruiting
- Depressive Disorder, Major
- +2 more
- aiTBS
- +2 more
-
Ghent, East-Flanders, BelgiumUniversity Hospital Ghent
Dec 6, 2022
Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)
Not yet recruiting
- Depression in Old Age
- Fragility Fracture
- Duloxetine 30 mg
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
May 9, 2023
Retinal Nerve Fiber Layer in First Episode Depressive Patients
Enrolling by invitation
- Unipolar Depression
-
Diyarbakır, TurkeySağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Resear
Mar 16, 2021
None (i.e. Healthy Volunteers) Trial in Ottawa (Levomilnacipran, Duloxetine, Placebos)
Active, not recruiting
- None (i.e. Healthy Volunteers)
- Levomilnacipran
- +2 more
-
Ottawa, Ontario, CanadaInstitute of Mental Health Research, Royal Ottawa Mental Health
Oct 5, 2021
SSRI's and the Rate of Progression From MCI to Dementia
Recruiting
- Mild Cognitive Impairment
- +2 more
-
Columbus, OhioThe Ohio State University
Sep 8, 2021
PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written
Recruiting
- PTSD
- Selective serotonin reuptake inhibitor
- +2 more
-
North Little Rock, Arkansas
- +15 more
Aug 2, 2022
Meniere Disease Trial in Charleston (Venlafaxine, Placebo oral tablet)
Recruiting
- Meniere Disease
- Venlafaxine
- Placebo oral tablet
-
Charleston, South CarolinaMedical Univeristy of South Carolina
Dec 2, 2021
Risk Factors for AD-Associated Switch to Mania
Completed
- Bipolar Disorder
- Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
-
Barcelona, Catalonia, SpainHospital Clinic Barcelona
Nov 17, 2021
Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)
Not yet recruiting
- Neurodevelopmental Disorders
- +25 more
- Sertraline
- Placebo
-
Calgary, Alberta, Canada
- +6 more
Oct 11, 2023
Tibial Plateau Fracture, Pain, Postoperative Trial in Boston, Valhalla (Duloxetine, Placebo, Standard of care (SOC) for tibial
Not yet recruiting
- Tibial Plateau Fracture
- Pain, Postoperative
- Duloxetine
- +2 more
-
Boston, Massachusetts
- +1 more
Aug 6, 2022
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)
Completed
- Depression
- +7 more
- Beating the Blues (BtB)
- +3 more
-
Indianapolis, IndianaIUPUI Department of Psychology
Aug 30, 2021
Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)
Completed
- Depressive Disorder, Major
- Esketamine 28 mg
- +6 more
-
Ciudad Autonoma de Buenos Aires, Argentina
- +170 more
Sep 13, 2022
Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)
Recruiting
- Depressive Disorder, Major
- Seltorexant
- Placebo
-
San Diego, California
- +26 more
Aug 17, 2022
Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and
Not yet recruiting
- Hypercapnia
- Ventilatory Depression
- Placebo and Oxycodone
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Jul 20, 2022
Obsessive Compulsive Disorder Trial in Hamilton (Topiramate, )
Completed
- Obsessive Compulsive Disorder
- Topiramate
- placebo
-
Hamilton, Ontario, CanadaMacAnxiety Research Centre
Aug 31, 2020
Pulmonary Arterial Hypertension Trial in Dallas (Fluoxetine)
Completed
- Pulmonary Arterial Hypertension
-
Dallas, TexasUT Southwestern Medical Center
Jun 24, 2020
OCD Trial (N-Acetylcysteine, )
Terminated
- Obsessive-Compulsive Disorder
- N-Acetylcysteine
- placebo
- (no location specified)
Mar 31, 2020
Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of
Withdrawn
- Stroke, Ischemic
- Administration of SSRI escitalopram
- +2 more
-
White Plains, New YorkBurke Neurological Institute
Jul 19, 2021